| Sacituzumab govitecan in metastatic triple-negative breast cancer A Bardia, SA Hurvitz, SM Tolaney, D Loirat, K Punie, M Oliveira, A Brufsky, ... New England journal of medicine 384 (16), 1529-1541, 2021 | 837 | 2021 |
| Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer A Bardia, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, A Zelnak, ... Annals of Oncology 32 (9), 1148-1156, 2021 | 185 | 2021 |
| Association of comorbidities with overall survival in myelodysplastic syndrome: development of a prognostic model K Naqvi, G Garcia-Manero, S Sardesai, J Oh, CE Vigil, S Pierce, X Lei, ... Journal of Clinical Oncology 29 (16), 2240, 2011 | 175 | 2011 |
| Pexidartinib, a novel small molecule CSF-1R inhibitor in use for tenosynovial giant cell tumor: a systematic review of pre-clinical and clinical development B Benner, L Good, D Quiroga, TE Schultz, M Kassem, WE Carson, ... Drug design, development and therapy, 1693-1704, 2020 | 117 | 2020 |
| Flavonoids: New frontier for immuno-regulation and breast cancer control M Sudhakaran, S Sardesai, AI Doseff Antioxidants 8 (4), 103, 2019 | 92 | 2019 |
| Estrogen receptor beta (ERβ): a ligand activated tumor suppressor R Mal, A Magner, J David, J Datta, M Vallabhaneni, M Kassem, ... Frontiers in Oncology 10, 587386, 2020 | 78 | 2020 |
| Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivors AM Quick, F Zvinovski, C Hudson, A Hundley, C Evans, A Suresh, ... Supportive Care in Cancer 28, 3669-3677, 2020 | 39 | 2020 |
| Progression-free survival for real-world use of palbociclib in hormone receptor-positive metastatic breast cancer J Wilkie, MA Schickli, MJ Berger, M Lustberg, R Reinbolt, A Noonan, ... Clinical breast cancer 20 (1), 33-40, 2020 | 33 | 2020 |
| Abstract GS3-06: Biomarker evaluation in the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer SA Hurvitz, SM Tolaney, K Punie, D Loirat, M Oliveira, K Kalinsky, ... Cancer Research 81 (4_Supplement), GS3-06-GS3-06, 2021 | 31 | 2021 |
| Worry and rumination in breast cancer patients: perseveration worsens self-rated health ME Renna, M Rosie Shrout, AA Madison, M Lustberg, SP Povoski, ... Journal of behavioral medicine 44, 253-259, 2021 | 30 | 2021 |
| Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy AM Quick, F Zvinovski, C Hudson, A Hundley, C Evans, JA Stephens, ... Menopause 28 (6), 642-649, 2021 | 26 | 2021 |
| A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer S Sardesai, M Badawi, E Mrozek, E Morgan, M Phelps, J Stephens, L Wei, ... Investigational new drugs 38, 1400-1410, 2020 | 24 | 2020 |
| Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple … J O’Shaughnessy, A Brufsky, HS Rugo, SM Tolaney, K Punie, S Sardesai, ... Breast cancer research and treatment 195 (2), 127-139, 2022 | 23 | 2022 |
| Inhibiting fatty acid synthase with omeprazole to improve efficacy of neoadjuvant chemotherapy in patients with operable TNBC SD Sardesai, A Thomas, C Gallagher, F Lynce, YL Ottaviano, TJ Ballinger, ... Clinical Cancer Research 27 (21), 5810-5817, 2021 | 22 | 2021 |
| Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective study E Morgan, A Suresh, A Ganju, DG Stover, R Wesolowski, S Sardesai, ... World journal of surgical oncology 18, 1-12, 2020 | 21 | 2020 |
| Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer S Sardesai, J Sukumar, M Kassem, M Palettas, J Stephens, E Morgan, ... Cardio-Oncology 6, 1-9, 2020 | 18 | 2020 |
| TTF-1 positive primary small cell carcinoma of the breast: a case report and review of the literature H Boutrid, M Kassem, G Tozbikian, E Morgan, J White, M Shah, ... Frontiers in Endocrinology 11, 228, 2020 | 18 | 2020 |
| Genomic features of rapid versus late relapse in triple negative breast cancer Y Zhang, S Asad, Z Weber, D Tallman, W Nock, M Wyse, JF Bey, KL Dean, ... BMC cancer 21 (1), 568, 2021 | 17 | 2021 |
| Long-Term Follow-Up of Fractional CO2 Laser Therapy for Genitourinary Syndrome of Menopause in Breast Cancer Survivors AM Quick, A Hundley, C Evans, JA Stephens, B Ramaswamy, ... Journal of Clinical Medicine 11 (3), 774, 2022 | 15 | 2022 |
| Treating alpelisib-induced hyperglycemia with very low carbohydrate diets and sodium-glucose co-transporter 2 inhibitors: a case series T Blow, PN Hyde, JN Falcone, A Neinstein, N Vasan, R Chitkara, MA Hurd, ... Integrative cancer therapies 20, 15347354211032283, 2021 | 15 | 2021 |
